We are live on
!
Find out more
VCG
Vantage Consulting Group Portfolio holdings
AUM
$19.7M
1-Year Est. Return
280.87%
This Fund
S&P 500
This Quarter
Est. Return
+17.65%
1 Year Est. Return
+280.87%
3 Year Est. Return
+261.08%
5 Year Est. Return
+180.34%
10 Year Est. Return
–
AUM
$1.23B
AUM Growth
–
Cap. Flow
+$1.06B
Cap. Flow
% of AUM
86.51%
Top 10 Holdings %
Top 10 Hldgs %
94.5%
Holding
1,884
New
1,883
Increased
–
Reduced
–
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Royalty Pharma
RPRX
|
+$911M |
| 2 |
ADC Therapeutics
ADCT
|
+$55.1M |
| 3 |
KYNB
Kyntra Bio
KYNB
|
+$25.5M |
| 4 |
ITCI
Intra-Cellular Therapies Inc.
ITCI
|
+$5.96M |
| 5 |
Kroger
KR
|
+$366K |
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 95.04% |
| 2 | Technology | 0.89% |
| 3 | Consumer Discretionary | 0.79% |
| 4 | Industrials | 0.61% |
| 5 | Consumer Staples | 0.61% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1351
Acuity Brands
AYI
$9.83B
| $7K | ﹤0.01% |
+59
| New | +$6.33K |
|
|
BLD
1352
DELISTED
TopBuild
BLD
| $7K | ﹤0.01% |
+36
| New | +$6.37K |
|
1353
Builders FirstSource
BLDR
$7.15B
| $7K | ﹤0.01% |
+168
| New | +$5.95K |
|
1354
Commercial Metals
CMC
$7.6B
| $7K | ﹤0.01% |
+330
| New | +$6.85K |
|
1355
Compass Minerals
CMP
$1.23B
| $7K | ﹤0.01% |
+108
| New | +$6.69K |
|
1356
Concentrix
CNXC
$1.5B
| $7K | ﹤0.01% |
+75
| New | +$7.5K |
|
1357
CRH
CRH
$63.2B
| $7K | ﹤0.01% |
+156
| New | +$6.13K |
|
1358
Diageo
DEO
$49B
| $7K | ﹤0.01% |
+41
| New | +$6.11K |
|
1359
EQT Corp
EQT
$33.3B
| $7K | ﹤0.01% |
+587
| New | +$8.46K |
|
1360
FTI Consulting
FCN
$4.4B
| $7K | ﹤0.01% |
+65
| New | +$7K |
|
1361
Federated Hermes
FHI
$4.55B
| $7K | ﹤0.01% |
+254
| New | +$6.76K |
|
1362
H.B. Fuller
FUL
$2.97B
| $7K | ﹤0.01% |
+144
| New | +$7.3K |
|
1363
Innospec
IOSP
$2.12B
| $7K | ﹤0.01% |
+78
| New | +$6.05K |
|
1364
ORIX
IX
$44B
| $7K | ﹤0.01% |
+475
| New | +$6.7K |
|
|
JHG
1365
DELISTED
Janus Henderson
JHG
| $7K | ﹤0.01% |
+229
| New | +$6.54K |
|
1366
James Hardie Industries
JHX
$15.3B
| $7K | ﹤0.01% |
+220
| New | +$5.99K |
|
1367
Kennametal
KMT
$2.59B
| $7K | ﹤0.01% |
+206
| New | +$7.08K |
|
1368
Lear
LEA
$6.54B
| $7K | ﹤0.01% |
+41
| New | +$5.77K |
|
1369
Littelfuse
LFUS
$11.2B
| $7K | ﹤0.01% |
+27
| New | +$5.98K |
|
1370
Lennox International
LII
$14.4B
| $7K | ﹤0.01% |
+26
| New | +$7.39K |
|
1371
Manhattan Associates
MANH
$11.2B
| $7K | ﹤0.01% |
+67
| New | +$6.59K |
|
1372
Navient
NAVI
$789M
| $7K | ﹤0.01% |
+694
| New | +$6.59K |
|
1373
Nabors Industries
NBR
$1.27B
| $7K | ﹤0.01% |
+117
| New | +$5.16K |
|
1374
nVent Electric
NVT
$24.9B
| $7K | ﹤0.01% |
+290
| New | +$6.11K |
|
1375
ONE Gas
OGS
$4.87B
| $7K | ﹤0.01% |
+95
| New | +$7.18K |
|
Similar funds
MVG
NCM
FFGIM
PIM
HFG
SWM
ICM
SM
Vantage Consulting Group's Q4 2020 Portfolio in Review
Q4 2020 is the first quarter with a 13F filing on record for Vantage Consulting Group, which disclosed 1,884 positions worth $1.23B. Its ten largest holdings account for 94% of the portfolio.
Its largest position is Royalty Pharma: 21,477,282 shares worth $1.07B.
By sector, the portfolio is most concentrated in Healthcare at 95% of assets, followed by Technology and Consumer Discretionary.
- Vantage Consulting Group's largest Q4 2020 buy was Royalty Pharma: 21,477,282 shares worth $1.07B.
- Vantage Consulting Group's ten largest holdings make up 94% of its $1.23B portfolio in Q4 2020.
- Vantage Consulting Group disclosed 1,884 positions in Q4 2020, its first 13F filing on record.
Based on Vantage Consulting Group's 13F filing for Q4 2020, filed 12 Feb 2021.